A trial now underway at the Cleveland Clinic and the MetroHealth Medical Center is testing a device-based treatment that could help the more than 5 million people suffering from heart-failure, according to the Cleveland Plain Dealer.
The trial, called Increase of Vagal Tone in Heart Failure, or INOVATE-HF, tests an implant, called CardioFit, that stimulates a nerve in the neck to influence the heart. The device is implanted underneath the skin of the chest and stimtulates the vagal nerve, which travels from the brain to the heart.
The study follows Class III patients for 5 1/2 years to measure the safety of the device, hospitalization rate, and quality of life.
According to the Plain Dealer, the CardioFit offers a less expensive option than what is currently available.
Click here for more information on the trial treatment, from the Cleveland Plain Dealer.
Get curated news on YOUR industry.
Enter your email to receive our newsletters.Latest from Today's Medical Developments
- Blum-Novotest opens new Competence Center in Erlanger, Kentucky
- HydroPlasma: The future of surface cleaning in high-tech industries
- Heule partners with Center for Machining Excellence
- Down the road: What really is next for electric vehicles?
- Driving successful medtech innovation
- Last call for July’s medical manufacturing Lunch + Learn!
- Transform What’s Possible with the Okuma MULTUS U3000
- Okuma: Extraordinary Starts Where Limits End
